FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CRESPO, E.
Right arrow Articles by ACUÑA-CASTROVIEJO, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CRESPO, E.
Right arrow Articles by ACUÑA-CASTROVIEJO, D.
(The FASEB Journal. 1999;13:1537-1546.)
© 1999 FASEB

Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats

ELENA CRESPO*, MANUEL MACÍAS*, DAVID POZO{dagger}, GERMAINE ESCAMES*, MIGUEL MARTÍN*, FRANCISCO VIVES*, JUAN M. GUERRERO{dagger} and DARÍO ACUÑA-CASTROVIEJO*1

* Departamento de Fisiología, Instituto de Biotecnología, Universidad de Granada, Spain;
{dagger} Departamento de Bioquímica Médica y Biología Molecular, Facultad de Medicina, Universidad de Sevilla, Spain

1Correspondence: Departamento de Fisiología, Facultad de Medicina, Avda. de Madrid 11, E-18012 Granada, Spain. E-mail: dacuna{at}goliat.ugr.es

We evaluated the role of melatonin in endotoxemia caused by lipopolysaccharide (LPS) in unanesthetized rats. The expression of inducible isoform of nitric oxide synthase (iNOS) and the increase in the oxidative stress seem to be responsible for the failure of lungs, liver, and kidneys in endotoxemia. Bacterial LPS (10 mg/kg b.w) was i.v. injected 6 h before rats were killed and melatonin (10–60 mg/kg b.w.) was i.p. injected before and/or after LPS. Endotoxemia was associated with a significant rise in the serum levels of aspartate and alanine aminotransferases, {gamma}-glutamyl-transferase, alkaline phosphatase, creatinine, urea, and uric acid, and hence liver and renal dysfunction. LPS also increased serum levels of cholesterol and triglycerides and reduced glucose levels. Melatonin administration counteracted these organ and metabolic alterations at doses ranging between 20 and 60 mg/kg b.w. Melatonin significantly decreased lung lipid peroxidation and counteracted the LPS-induced NO levels in lungs and liver. Our results also show an inhibition of iNOS activity in rat lungs by melatonin in a dose-dependent manner. Expression of iNOS mRNA in lungs and liver was significantly decreased by melatonin (60 mg/kg b.w., 58–65%). We conclude that melatonin inhibits NO production mainly by inhibition of iNOS expression. The inhibition of NO levels may account for the protection of the indoleamine against LPS-induced endotoxemia in rats.—Crespo, E., Macías, M., Pozo, D., Escames, G., Martín, M., Vives, F., Guerrero, J. M., Acuña-Castroviejo, D. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats.


Key Words: iNOS • endotoxic shock • genomic effects




This article has been cited by other articles:


Home page
BloodHome page
W.-G. Deng, S.-T. Tang, H.-P. Tseng, and K. K. Wu
Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding
Blood, July 15, 2006; 108(2): 518 - 524.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Z. Pei, S. F. Pang, and R. T. F. Cheung
Administration of Melatonin After Onset of Ischemia Reduces the Volume of Cerebral Infarction in a Rat Middle Cerebral Artery Occlusion Stroke Model
Stroke, March 1, 2003; 34(3): 770 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Matsuzaki, M. Kuwamura, R. Yamaji, H. Inui, and Y. Nakano
Inflammatory Responses to Lipopolysaccharide Are Suppressed in 40% Energy-Restricted Mice
J. Nutr., August 1, 2001; 131(8): 2139 - 2144.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. van der Loo, R. Labugger, J. N. Skepper, M. Bachschmid, J. Kilo, J. M. Powell, M. Palacios-Callender, J. D. Erusalimsky, T. Quaschning, T. Malinski, et al.
Enhanced Peroxynitrite Formation Is Associated with Vascular Aging
J. Exp. Med., December 11, 2000; 192(12): 1731 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. León, M. Macías, G. Escames, E. Camacho, H. Khaldy, M. Martín, A. Espinosa, M. A. Gallo, and D. Acuña-Castroviejo
Structure-Related Inhibition of Calmodulin-Dependent Neuronal Nitric-Oxide Synthase Activity by Melatonin and Synthetic Kynurenines
Mol. Pharmacol., November 1, 2000; 58(5): 967 - 975.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Zhang, L. M. Walker, J. A. Hinson, and P. R. Mayeux
Oxidant Stress in Rat Liver after Lipopolysaccharide Administration: Effect of Inducible Nitric-Oxide Synthase Inhibition
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 968 - 972.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The Federation of American Societies for Experimental Biology.